Laboratory for Biomedical Microfluidics

The Biomedical Microfluid Laboratory (LBMM) at EPFL focuses on developing innovative approaches for drug discovery and personalized cancer therapy. With a strong translational focus, LBMM collaborates with the pharma industry, promotes entrepreneurship, and facilitates the transition of research results into clinical trials. The lab's interdisciplinary team includes experts from biology, genomics, bioinformatics, engineering, and physics. Using microscopic droplets as miniaturized reaction vessels, LBMM achieves significantly increased throughput, performs screens on the single-cell level, and minimizes sample consumption. Research themes include therapeutic antibodies and T-cells, personalized medicine, genomics, and continuous development of microfluidic technology.